Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program
TEL AVIV, Israel and BETHESDA, Md., June 3, 2021 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program for the development of a Breast Cancer…
Comments Off on Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program